ASSIST for Childhood Apraxia of Speech
(ASSIST Trial)
Trial Summary
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that ASSIST for Childhood Apraxia of Speech is an effective treatment?
The available research shows that ASSIST, which involves integral stimulation treatment, is effective for most children with Childhood Apraxia of Speech. In a study, four out of six children showed better speech improvements with a high amount of practice and massed practice sessions compared to low and distributed practice. This suggests that ASSIST can lead to significant speech motor learning improvements. Additionally, another treatment called TEMPOSM also showed positive results, with children improving in speech fluency and accuracy, and these gains were maintained even after the treatment ended. This supports the idea that structured and intensive practice is beneficial for treating Childhood Apraxia of Speech.12345
What safety data exists for ASSIST treatment for Childhood Apraxia of Speech?
The provided research does not directly address safety data for ASSIST or Apraxia of Speech Systematic Integral Stimulation Treatment. The studies focus on treatment efficacy and outcomes for apraxia of speech, including error reduction therapy, Autism-Centered Therapy for Childhood Apraxia of Speech, and practice intensity in treatment. However, none of these studies specifically mention safety data or adverse effects related to ASSIST treatment.12367
Is the ASSIST treatment a promising option for childhood apraxia of speech?
Yes, the ASSIST treatment is promising for childhood apraxia of speech. It helps children improve their speech by focusing on motor skills and coordination needed for speaking. Studies show that children can make significant progress with this treatment, improving their ability to speak clearly and effectively.4891011
What is the purpose of this trial?
Childhood apraxia of speech (CAS) is a pediatric motor speech disorder that impairs the planning of movements needed for intelligible speech. Children with CAS often show little or slow progress in standard speech therapy. This research is a Phase 1 study that tests initial efficacy and optimal parameters of a theoretically based integral stimulation treatment called ASSIST (Apraxia of Speech Systematic Integral Stimulation Treatment). In three small randomized group design studies, children (N=20 per study) receive 16 hours of individual ASSIST. The three studies systematically investigate treatment intensity (2 vs. 4 weeks) and two critical aspects of target selection: complexity (simple vs. complex target) and lexicality (words vs. nonwords). Each study also systematically examines the effect of treatment on functional outcome measures, including parent ratings of intelligibility and communicative participation, and objective intelligibility measures obtained from unfamiliar listeners.
Research Team
Edwin Maas, Ph.D.
Principal Investigator
Temple University
Eligibility Criteria
This trial is for English-speaking children aged between 4 and 9 years with Childhood Apraxia of Speech (CAS). They must have a speech sound disorder, be able to speak at least 50 words, show communicative intent, and have normal hearing. Children with significant oral impairments, unrelated health issues that could affect participation, or a primary diagnosis other than CAS are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Block 1
Children receive intensive ASSIST treatment with 16 hours of individual sessions over two weeks
Treatment Block 2
Continuation of intensive ASSIST treatment with another 16 hours of individual sessions over two weeks
Follow-up
Participants are monitored for changes in speech accuracy and functional outcomes post-treatment
Treatment Details
Interventions
- ASSIST
Find a Clinic Near You
Who Is Running the Clinical Trial?
Temple University
Lead Sponsor